Literature DB >> 33441113

A qualitative study of women and partners from Lebanon and Quebec regarding an expanded scope of noninvasive prenatal testing.

Hazar Haidar1, Jessica Le Clerc-Blain2, Meredith Vanstone3, Anne-Marie Laberge4,5,6, Gilles Bibeau7, Labib Ghulmiyyah8, Vardit Ravitsky9.   

Abstract

BACKGROUND: In the near future, developments in non-invasive prenatal testing (NIPT) may offer couples the opportunity to expand the range of genetic conditions tested with this technology. This possibility raises a host of ethical and social concerns, such as the type of information (medical vs. non-medical information) that couples might be exposed to and how this might complicate their informed decision-making. Currently, only limited research, mainly carried out in western countries, was conducted on women's and partners' views regarding the potential expansion of NIPT.
METHODS: This study used semi-structured interviews with pregnant women and their partners to explore their views on future potential NIPT applications such as non-medical sex selection and non-medical traits, paternity testing, and NIPT use for fetal whole genome sequencing (FWGS). It was conducted in Lebanon and Quebec, as case studies to explore the impact of cultural differences on these views.
RESULTS: We found no differences and many similarities when comparing the perceptions of participants in both contexts. While couples in both settings disapproved of the use of NIPT for non-medical sex selection and non-medical traits such as physical characteristics, they were near-unanimous about their support for its use for paternity testing in specific cases, such as legal doubts or conflicts related to the identity of the father. Participants were more ambivalent about NIPT for Fetal Whole Genome Sequencing. They supported this use to detect conditions that would express at birth or early childhood, while objecting to testing for adult-onset conditions.
CONCLUSIONS: These results can further inform the debate on the future uses of NIPT and future policy related its implementation.

Entities:  

Keywords:  Cultural contexts; Fetal whole genome sequencing; Future uses; Interviews; Lebanon; Noninvasive prenatal testing; Paternity; Qualitative; Quebec; Sex selection

Year:  2021        PMID: 33441113     DOI: 10.1186/s12884-020-03538-y

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.007


  27 in total

1.  Noninvasive whole-genome sequencing of a human fetus.

Authors:  Jacob O Kitzman; Matthew W Snyder; Mario Ventura; Alexandra P Lewis; Ruolan Qiu; Lavone E Simmons; Hilary S Gammill; Craig E Rubens; Donna A Santillan; Jeffrey C Murray; Holly K Tabor; Michael J Bamshad; Evan E Eichler; Jay Shendure
Journal:  Sci Transl Med       Date:  2012-06-06       Impact factor: 17.956

2.  Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.

Authors:  Y M Dennis Lo; K C Allen Chan; Hao Sun; Eric Z Chen; Peiyong Jiang; Fiona M F Lun; Yama W Zheng; Tak Y Leung; Tze K Lau; Charles R Cantor; Rossa W K Chiu
Journal:  Sci Transl Med       Date:  2010-12-08       Impact factor: 17.956

3.  Prenatal whole genome sequencing: just because we can, should we?

Authors:  Greer Donley; Sara Chandros Hull; Benjamin E Berkman
Journal:  Hastings Cent Rep       Date:  2012-06-20       Impact factor: 2.683

4.  Cell-free DNA Analysis for Noninvasive Examination of Trisomy.

Authors:  Mary E Norton; Ronald J Wapner
Journal:  N Engl J Med       Date:  2015-12-24       Impact factor: 91.245

5.  Noninvasive prenatal testing to analyze the fetal genome.

Authors:  Mary E Norton
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-30       Impact factor: 11.205

Review 6.  Sequencing of Circulating Cell-free DNA during Pregnancy.

Authors:  Diana W Bianchi; Rossa W K Chiu
Journal:  N Engl J Med       Date:  2018-08-02       Impact factor: 91.245

7.  No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes.

Authors:  Francois Audibert; Isabelle De Bie; Jo-Ann Johnson; Nanette Okun; R Douglas Wilson; Christine Armour; David Chitayat; Raymond Kim
Journal:  J Obstet Gynaecol Can       Date:  2017-09

Review 8.  Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis.

Authors:  Caroline F Wright; Yinghui Wei; Julian P T Higgins; Gurdeep S Sagoo
Journal:  BMC Res Notes       Date:  2012-09-01

9.  DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.

Authors:  Glenn E Palomaki; Cosmin Deciu; Edward M Kloza; Geralyn M Lambert-Messerlian; James E Haddow; Louis M Neveux; Mathias Ehrich; Dirk van den Boom; Allan T Bombard; Wayne W Grody; Stanley F Nelson; Jacob A Canick
Journal:  Genet Med       Date:  2012-02-02       Impact factor: 8.822

10.  ACMG statement on noninvasive prenatal screening for fetal aneuploidy.

Authors:  Anthony R Gregg; S J Gross; R G Best; K G Monaghan; K Bajaj; B G Skotko; B H Thompson; M S Watson
Journal:  Genet Med       Date:  2013-04-04       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.